Peptide Field Reference

BPC-157

Body Protection Compound — the "Wolverine" healing peptide for injury recovery, gut health, and tissue repair.

What is BPC-157

BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide derived from a protein found naturally in human gastric juice. It has been studied extensively in rodent models and is one of the most popular healing peptides in our peptide library.

It has earned the nickname "the Wolverine peptide" due to its remarkable ability to accelerate healing of muscles, tendons, ligaments, and gut tissue. Users consistently report dramatically accelerated recovery from injuries, surgeries, and chronic pain conditions. For systemic healing, many stack BPC-157 with TB-500.

BPC-157 works through multiple pathways — promoting angiogenesis (new blood vessel formation), modulating growth factors, and having systemic anti-inflammatory effects. For gut-specific inflammation, KPV is another option to consider. BPC-157 has a strong safety profile in animal studies with no LD50 established (meaning no lethal dose was found).

§ 02

How it works

Angiogenesis Promotion: BPC-157 stimulates the formation of new blood vessels (angiogenesis), which is critical for delivering oxygen and nutrients to damaged tissue. This is one of the primary mechanisms behind its rapid healing effects.

Growth Factor Modulation: BPC-157 upregulates growth hormone receptors and promotes the synthesis of growth factors including VEGF, which drives tissue regeneration.

Nitric Oxide Pathway: BPC-157 activates the NO-cGMP pathway, improving blood flow to injured areas and reducing inflammation.

Gut-Brain Axis: BPC-157 modulates the vagus nerve and has protective effects on the entire gastrointestinal tract, making it useful for IBS, leaky gut, NSAID-induced damage, and IBD.

BPC-157 in the Philippines

BPC-157 has no Philippine pharmaceutical equivalent. It is not registered with FDA Philippines, not stocked at Mercury Drug or Watsons, and not prescribed at hospital pharmacies. Every BPC-157 protocol running in the country is research-grade.

Most Manila-based users source 5mg or 10mg lyophilized vials from local suppliers shipping cold-chain via Lalamove same-day to Salcedo, Legazpi, BGC, Rockwell, and Quezon City. Cebu and Davao routes use airline-courier with overnight cold packs. Verified third-party COA per batch is the minimum quality bar — peptide content varies wildly between unverified suppliers, and BPC-157 is a common target for low-dose adulteration because users rarely notice missed effect on a 4-week tendon-healing protocol.

Self-directed BPC-157 protocols often run alongside a sports-medicine or orthopedic consult at Makati Med, St. Luke's BGC, or The Medical City — typically PHP 1,800–3,500 for the consult plus PHP 4,500–8,500 for an MRI if injury staging is needed. The clinic doesn't prescribe the peptide itself but provides imaging and recovery markers.

Hospitals · prescription routes

Makati Medical Center — sports medicineMakatiImaging and recovery monitoring; will not prescribe research peptides
St. Luke's Medical Center BGC — orthopedicsBGCMRI and rehab medicine; concierge program for expat athletes
The Medical City — orthopedicsPasigStrong sports-medicine department; affordable imaging
Asian Hospital — sports medicineAlabangSouth Metro option

Pharmacies · branches with confirmed stock

Not applicable — no retail availability—Research-grade only; verify COA per batch from supplier

Real PH pricing · observed

Research-grade BPC-157 5mg vial₱1,800–2,800$32–50Local supplier with COA, May 2026
Research-grade BPC-157 10mg vial₱2,800–4,500$50–80Bulk pricing
Sports medicine consult₱1,800–3,500$32–63Makati Med / St. Luke's BGC
MRI single joint (musculoskeletal)₱8,500–14,000$152–250Makati Med imaging center

Customs · Import reality

BPC-157 imported as research material is generally tolerated by BOC at personal-use volumes (under 30 vials per shipment) when invoiced as "research peptide" rather than by name. The compound is not a scheduled substance under PH law, but unregistered injectables can still be detained at NAIA inspection. Most suppliers cover one reshipment if a BOC seizure occurs — confirm policy in writing before ordering.

§ 03

Reported benefits

01Accelerated healing of tendons, ligaments, and muscle tears
02Gut healing and protection (IBS, leaky gut, NSAID damage, IBD)
03Reduced inflammation and pain in injured areas
04Joint repair and cartilage protection
05Neuroprotective effects (brain injury, stroke recovery)
06Possible protection against NSAID-induced gut damage
07Systemic anti-inflammatory properties

§ 04

Dosing protocol

Suggested titration
Phase	Dose	Frequency	Duration
Systemic (injection)	250–500mcg	Once daily	4–8 weeks
Injury-targeted	250–500mcg	Twice daily near injury site	4–6 weeks
Gut Protocol	500mcg	Once daily (oral or sub-q)	4–8 weeks
Maintenance	250mcg	Once daily	Ongoing as needed

Always start at the lowest effective dose and titrate up gradually.

§ 05

Side effects

Common

Injection site redness (minor, resolves quickly)
Mild dizziness in first week (usually transient)
Vivid dreams reported by some users
Slight nausea when taken orally without food

Rare

·Theoretical concern about promoting growth in existing cancers (avoid with active cancer)
·Headache in some users at higher doses

§ 06

Who should not use BPC-157

§ 07

What to expect

Day 1–7

Some users notice reduced inflammation and pain within the first week. Gut users may notice improvements in bloating and regularity quickly.

Week 2–3

Most users report noticeable improvements in injury pain, mobility, and recovery. Tendon/ligament injuries typically show the most dramatic early improvement.

Week 4–6

Significant tissue repair. Many users report resolving injuries that had been chronic for months or years. Quality of life improvements notable.

Week 8+

Most users complete their protocol. Some cycle off and resume when needed for new injuries. Long-term use is not thought to be necessary after healing.

§ 08

FAQ

Q-01

Should I inject BPC-157 near the injury or subcutaneously in the belly?

Both work. Injecting near the injury (perilesional) is thought to concentrate the effect locally. Subcutaneous injection in the belly (systemic) still reaches the injury via bloodstream. Most users do belly injections for convenience with good results.

Q-02

Can I stack BPC-157 with TB-500?

Yes, BPC-157 + TB-500 is one of the most popular healing stacks. They work through complementary mechanisms and the combination is widely reported to produce faster and more complete healing than either alone. See the Healing Stack Protocol. For longevity users, BPC-157 pairs well with NAD+ therapy protocols in the Philippines.

Q-03

Does BPC-157 need to be refrigerated?

Lyophilized (powder) BPC-157 can be stored at room temperature short-term but is best kept in a refrigerator or freezer for long-term storage. Once reconstituted, it must be refrigerated and used within 4–6 weeks. Always verify purity with a third-party COA before use, and source from the community-verified supplier list. For information on peptide legality in the Philippines, see our legality guide.

Q-04

Can BPC-157 be taken orally?

BPC-157 is one of the few peptides that appears to retain some bioactivity when taken orally, particularly for gut conditions. For systemic or injury effects, subcutaneous injection is significantly more effective.

§ 09

Where to get BPC-157 in the Philippines

See our community-verified supplier list with COA verification and cold-chain shipping to the Philippines.

View Supply Index

Primary sources

Citations supporting the clinical claims on this page. Each entry links to the primary record.

[01]
BPC-157 mechanism review — angiogenesis and tendon healing
Review
Sikiric P et al. "Brain-Gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications." Curr Neuropharmacol 2016;14(8):857-865.
DOI: 10.2174/1570159X13666160502153022
[02]
BPC-157 Achilles tendon outcomes — rat model
Mechanism
Krivic A et al. "Achilles detachment in rat and stable gastric pentadecapeptide BPC 157." J Orthop Res 2006;24(5):982-989.
DOI: 10.1002/jor.20096
[03]
BPC-157 corticosteroid-impaired wound healing
Mechanism
Tkalcevic VI et al. "Enhancement by PL 14736 of granulation and collagen organization in healing wounds and the potential role of egr-1 expression." Eur J Pharmacol 2007;570(1-3):212-221.
DOI: 10.1016/j.ejphar.2007.05.072
[04]
BPC-157 muscle injury and growth hormone receptor expression
Mechanism
Chang CH et al. "The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration." J Appl Physiol 2011;110(3):774-780.
DOI: 10.1152/japplphysiol.00945.2010
[05]
FDA bulk drug substance review — 503A compounding
Label
US FDA. "Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the FD&C Act." Decision: BPC-157 not on the 503A allowed list.
Source

Risk · Disclosure · Editorial Status

This page is editorial information for adults researching peptide therapy. It is not medical advice, not a prescription, and not an endorsement of any specific product, supplier, or protocol. Side effects can be serious and individual response varies. Talk to a licensed physician — ideally one with peptide-specific clinical experience — before starting any compound, adjusting a dose, or discontinuing therapy.

In the Philippines, GLP-1 medications are prescription-only under FDA Philippines regulation. Research-grade peptides occupy a regulatory gray area: import for personal research use is generally tolerated, but the Bureau of Customs reserves the right to inspect and detain shipments. Do not import for resale.

Editorial Status

Independent · Non-clinical

Affiliation

Not a clinic · Not a pharmacy

Last Updated

May 7, 2026

↗ Related peptides

TB-500 KPV ARA-290 GHK-Cu